Protective effect of agaro-oligosaccharides on gut dysbiosis and colon tumorigenesis in high-fat diet-fed mice

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 310, Issue 6, 2016, Pages G367-G375

  Higashimura, Yasuki ^a   Naito, Yuji ^a   Takagi, Tomohisa ^a   Uchiyama, Kazuhiko ^a   Mizushima, Katsura ^a   Ushiroda, Chihiro ^a   Ohnogi, Hiromu ^a,b   Kudo, Yoko ^b   Yasui, Madoka ^b   Inui, Seina ^b   Hisada, Takayoshi ^c   Honda, Akira ^d   Matsuzaki, Yasushi ^d   Yoshikawa, Toshikazu ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^b TAKARA BIO INC   (Japan)

^c 5F N   (Japan)

^d Tokyo Medical University Ibaraki Medical Center   (Japan)

Author keywords

Colon cancer; Deoxycholic acid; Gut microbiota; Lactobacillales; Short chain fatty acid

Indexed keywords

AGARO OLIGOSACCHARIDE; BILE ACID; DEOXYCHOLIC ACID; LACTIC ACID; OLIGOSACCHARIDE; UNCLASSIFIED DRUG; ENDOTOXIN; FATTY ACID; SEPHAROSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTEROIDES; BILE ACID BLOOD LEVEL; BILE ACID METABOLISM; CLOSTRIDIUM; COLON CARCINOGENESIS; CONTROLLED STUDY; DYSBIOSIS; FECES MICROFLORA; LACTOBACILLALES; LIPID DIET; MALE; MOUSE; NONHUMAN; PREVOTELLA; PRIORITY JOURNAL; SUPPLEMENTATION; ADVERSE EFFECTS; ANIMAL; BLOOD; C57BL MOUSE; CHEMICALLY INDUCED; CHEMISTRY; COLON TUMOR; DIETARY FIBER; FECES; METABOLISM; MICROBIOLOGY; MICROFLORA; OBESITY;

ANIMALS; BILE ACIDS AND SALTS; CLOSTRIDIUM; COLONIC NEOPLASMS; DIET, HIGH-FAT; DIETARY FIBER; DYSBIOSIS; ENDOTOXINS; FATTY ACIDS; FECES; LACTOBACILLALES; MALE; MICE; MICE, INBRED C57BL; MICROBIOTA; OBESITY; OLIGOSACCHARIDES; SEPHAROSE;

EID: 84979584538     PISSN: 01931857     EISSN: 15221547     Source Type: Journal    
DOI: 10.1152/ajpgi.00324.2015     Document Type: Article

References (50)

1. Ando M, Kaneko T, Watanabe R, Kikuchi S, Goto T, Iida T, Hishinuma T, Mano N, Goto J. High sensitive analysis of rat serum bile acids by liquid chromatography/electrospray ionization tandem mass spectrometry. J Pharm Biomed Anal 40: 1179–1186, 2006.
2. Azcarate-Peril MA, Sikes M, Bruno-Barcena JM. The intestinal microbiota, gastrointestinal environment and colorectal cancer: a putative role for probiotics in prevention of colorectal cancer? Am J Physiol Gastrointest Liver Physiol 301: G401–G424, 2011.
3. Bajzer M, Seeley RJ. Physiology: obesity and gut flora. Nature 444: 1009–1010, 2006.
4. Barman M, Unold D, Shifley K, Amir E, Hung K, Bos N, Salzman N. Enteric salmonellosis disrupts the microbial ecology of the murine gastrointestinal tract. Infect Immun 76: 907–915, 2008.
5. Bhattarai Y, Kashyap P. Agaro-oligosaccharides: a new frontier in the fight against colon cancer? Am J Physiol Gastrointest Liver Physiol (February 11, 2016). doi:10.1152/ajpgi.00049.2016.
6. Batta AK, Salen G, Holubec H, Brasitus TA, Alberts D, Earnest DL. Enrichment of the more hydrophilic bile acid ursodeoxycholic acid in the fecal water-soluble fraction after feeding to rats with colon polyps. Cancer Res 58: 1684–1687, 1998.
7. Bird RP. Observation and quantification of aberrant crypts in the murine colon treated with a colon carcinogen: preliminary findings. Cancer Lett 37: 147–151, 1987.
8. Brim H, Yooseph S, Zoetendal EG, Lee E, Torralbo M, Laiyemo AO, Shokrani B, Nelson K, Ashktorab H. Microbiome analysis of stool samples from African Americans with colon polyps. PLoS One 8: e81352, 2013.
9. Brown K, DeCoffe D, Molcan E, Gibson DL. Diet-induced dysbiosis of the intestinal microbiota and the effects on immunity and disease. Nutrients 4: 1095–1119, 2012.
10. Burnat G, Majka J, Konturek PC. Bile acids are multifunctional modulators of the Barrett’s carcinogenesis. J Physiol Pharmacol 61: 185–192, 2010.
11. Chen H, Yan X, Zhu P, Lin J. Antioxidant activity and hepatoprotective potential of agaro-oligosaccharides in vitro and in vivo. Nutr J 5: 31, 2006.
12. Chen HM, Yan XJ. Antioxidant activities of agaro-oligosaccharides with different degrees of polymerization in cell-based system. Biochim Biophys Acta 1722: 103–111, 2005.
13. Chen HM, Yu YN, Wang JL, Lin YW, Kong X, Yang CQ, Yang L, Liu ZJ, Yuan YZ, Liu F, Wu JX, Zhong L, Fang DC, Zou W, Fang JY. Decreased dietary fiber intake and structural alteration of gut microbiota in patients with advanced colorectal adenoma. Am J Clin Nutr 97: 1044–1052, 2013.
14. Collins SM. A role for the gut microbiota in IBS. Nat Rev Gastroenterol Hepatol 11: 497–505, 2014.
15. Cummings JH, Macfarlane GT. The control and consequences of bacterial fermentation in the human colon. J Appl Bacteriol 70: 443–459, 1991.
16. Delzenne NM, Neyrinck AM, Backhed F, Cani PD. Targeting gut microbiota in obesity: effects of prebiotics and probiotics. Nat Rev Endocrinol 7: 639–646, 2011.
17. Duncan SH, Belenguer A, Holtrop G, Johnstone AM, Flint HJ, Lobley GE. Reduced dietary intake of carbohydrates by obese subjects results in decreased concentrations of butyrate and butyrate-producing bacteria in feces. Appl Environ Microbiol 73: 1073–1078, 2007.
18. Dvorak K, Payne CM, Chavarria M, Ramsey L, Dvorakova B, Bernstein H, Holubec H, Sampliner RE, Guy N, Condon A, Bernstein C, Green SB, Prasad A, Garewal HS. Bile acids in combination with low pH induce oxidative stress and oxidative DNA damage: relevance to the pathogenesis of Barrett’s oesophagus. Gut 56: 763–771, 2007.
19. Enoki T, Tominaga T, Takashima F, Ohnogi H, Sagawa H, Kato I. Anti-tumor-promoting activities of agaro-oligosaccharides on two-stage mouse skin carcinogenesis. Biol Pharm Bull 35: 1145–1149, 2012.
20. Gill CI, Rowland IR. Diet and cancer: assessing the risk. Br J Nutr 88, Suppl 1: S73–S87, 2002.
21. Heuman DM. Quantitative estimation of the hydrophilic-hydrophobic balance of mixed bile salt solutions. J Lipid Res 30: 719–730, 1989.
22. Hinnebusch BF, Meng S, Wu JT, Archer SY, Hodin RA. The effects of short-chain fatty acids on human colon cancer cell phenotype are associated with histone hyperacetylation. J Nutr 132: 1012–1017, 2002.
23. Hu X, Bonde Y, Eggertsen G, Rudling M. Muricholic bile acids are potent regulators of bile acid synthesis via a positive feedback mechanism. J Intern Med 275: 27–38, 2014.
24. Inagaki A, Ichikawa H, Sakata T. Inhibitory effect of succinic acid on epithelial cell proliferation of colonic mucosa in rats. J Nutr Sci Vitaminol (Tokyo) 53: 377–379, 2007.
25. Jakobsdottir G, Xu J, Molin G, Ahrne S, Nyman M. High-fat diet reduces the formation of butyrate, but increases succinate, inflammation, liver fat and cholesterol in rats, while dietary fibre counteracts these effects. PLoS One 8: e80476, 2013.
26. Kazlowski B, Pan CL, Ko YT. Separation and quantification of neoagaro- and agaro-oligosaccharide products generated from agarose digestion by beta-agarase and HCl in liquid chromatography systems. Carbohydr Res 343: 2443–2450, 2008.
27. Keku TO, Dulal S, Deveaux A, Jovov B, Han X. The gastrointestinal microbiota and colorectal cancer. Am J Physiol Gastrointest Liver Physiol 308: G351–G363, 2015.
28. Kish L, Hotte N, Kaplan GG, Vincent R, Tso R, Ganzle M, Rioux KP, Thiesen A, Barkema HW, Wine E, Madsen KL. Environmental particulate matter induces murine intestinal inflammatory responses and alters the gut microbiome. PLoS One 8: e62220, 2013.
29. Kitani K, Kanai S, Sato Y, Ohta M. Tauro alpha-muricholate is as effective as tauro beta-muricholate and tauroursodeoxycholate in preventing taurochenodeoxycholate-induced liver damage in the rat. Hepatology 19: 1007–1012, 1994.
30. Kondoh M, Shimada T, Fukada K, Morita M, Katada K, Higashimura Y, Mizushima K, Okamori M, Naito Y, Yoshikawa T. Beneficial effects of heat-treated Enterococcus faecalis FK-23 on high-fat diet-induced hepatic steatosis in mice. Br J Nutr 112: 868–875, 2014.
31. Lechner S, Muller-Ladner U, Schlottmann K, Jung B, McClelland M, Ruschoff J, Welsh J, Scholmerich J, Kullmann F. Bile acids mimic oxidative stress induced upregulation of thioredoxin reductase in colon cancer cell lines. Carcinogenesis 23: 1281–1288, 2002.
32. Macfarlane GT, Macfarlane S. Bacteria, colonic fermentation, and gastrointestinal health. J AOAC Int 95: 50–60, 2012.
33. McGarr SE, Ridlon JM, Hylemon PB. Diet, anaerobic bacterial metabolism, and colon cancer: a review of the literature. J Clin Gastroenterol 39: 98–109, 2005.
34. Midtvedt T. Microbial bile acid transformation. Am J Clin Nutr 27: 1341–1347, 1974.
35. Mortensen PB, Clausen MR. Short-chain fatty acids in the human colon: relation to gastrointestinal health and disease. Scand J Gastroenterol Suppl 216: 132–148, 1996.
36. Nagashima K, Hisada T, Sato M, Mochizuki J. Application of new primer-enzyme combinations to terminal restriction fragment length polymorphism profiling of bacterial populations in human feces. Appl Environ Microbiol 69: 1251–1262, 2003.
37. Nagashima K, Mochizuki J, Hisada T, Suzuki S, Shimomura K. Phylogenetic analysis of 16s ribosomal RNA gene sequences from human fecal microbiota and improved utility of terminal restriction fragment length polymorphism profiling. Biosci Microflora 25: 99–107, 2006.
38. Neyrinck AM, Possemiers S, Verstraete W, De Backer F, Cani PD, Delzenne NM. Dietary modulation of clostridial cluster XIVa gut bacteria (Roseburia spp.) by chitin-glucan fiber improves host metabolic alterations induced by high-fat diet in mice. J Nutr Biochem 23: 51–59, 2012.
39. Pachikian BD, Essaghir A, Demoulin JB, Catry E, Neyrinck AM, Dewulf EM, Sohet FM, Portois L, Clerbaux LA, Carpentier YA, Possemiers S, Bommer GT, Cani PD, Delzenne NM. Prebiotic approach alleviates hepatic steatosis: implication of fatty acid oxidative and cholesterol synthesis pathways. Mol Nutr Food Res 57: 347–359, 2013.
40. Pagnini C, Corleto VD, Mangoni ML, Pilozzi E, Torre MS, Marchese R, Carnuccio A, Giulio ED, Delle Fave G. Alteration of local microflora and alpha-defensins hyper-production in colonic adenoma mucosa. J Clin Gastroenterol 45: 602–610, 2011.
41. Ridlon JM, Kang DJ, Hylemon PB. Bile salt biotransformations by human intestinal bacteria. J Lipid Res 47: 241–259, 2006.
42. Sayin SI, Wahlstrom A, Felin J, Jantti S, Marschall HU, Bamberg K, Angelin B, Hyotylainen T, Oresic M, Backhed F. Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-betamuricholic acid, a naturally occurring FXR antagonist. Cell Metab 17: 225–235, 2013.
43. Shen J, Obin MS, Zhao L. The gut microbiota, obesity and insulin resistance. Mol Aspects Med 34: 39–58, 2013.
44. Suau A, Bonnet R, Sutren M, Godon JJ, Gibson GR, Collins MD, Dore J. Direct analysis of genes encoding 16S rRNA from complex communities reveals many novel molecular species within the human gut. Appl Environ Microbiol 65: 4799–4807, 1999.
45. Swann JR, Want EJ, Geier FM, Spagou K, Wilson ID, Sidaway JE, Nicholson JK, Holmes E. Systemic gut microbial modulation of bile acid metabolism in host tissue compartments. Proc Natl Acad Sci USA 108 Suppl 1: 4523–4530, 2011.
46. Takahashi M, Mutoh M, Kawamori T, Sugimura T, Wakabayashi K. Altered expression of beta-catenin, inducible nitric oxide synthase and cyclooxygenase-2 in azoxymethane-induced rat colon carcinogenesis. Carcinogenesis 21: 1319–1327, 2000.
47. Tannahill GM, Curtis AM, Adamik J, Palsson-McDermott EM, McGettrick AF, Goel G, Frezza C, Bernard NJ, Kelly B, Foley NH, Zheng L, Gardet A, Tong Z, Jany SS, Corr SC, Haneklaus M, Caffrey BE, Pierce K, Walmsley S, Beasley FC, Cummins E, Nizet V, Whyte M, Taylor CT, Lin H, Masters SL, Gottlieb E, Kelly VP, Clish C, Auron PE, Xavier RJ, O’Neill LA. Succinate is an inflammatory signal that induces IL-1beta through HIF-1alpha. Nature 496: 238–242, 2013.
48. Topping DL, Clifton PM. Short-chain fatty acids and human colonic function: roles of resistant starch and nonstarch polysaccharides. Physiol Rev 81: 1031–1064, 2001.
49. Voigt W, Thomas PJ, Hsia SL. Enzymic studies of bile acid metabolism. I. 6-beta-Hydroxylation of chenodeoxycholic and taurochenodeoxycholic acids by microsomal preparations of rat liver. J Biol Chem 243: 3493–3499, 1968.
50. Yoshimoto S, Loo TM, Atarashi K, Kanda H, Sato S, Oyadomari S, Iwakura Y, Oshima K, Morita H, Hattori M, Honda K, Ishikawa Y, Hara E, Ohtani N. Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome. Nature 499: 97–101, 2013.